
Published On: Jul 2022
Published On: Jul 2022
According to a new market research study on “APAC swabs collection kit market to 2028 – COVID-19 Impact Analysis and Forecast by Type, by Application, and Country” is expected to reach US$ 1,373.90 million by 2028 from US$ 982.61 million in 2021. The market is estimated to grow at a CAGR of 4.9% from 2021 to 2028. The report provides trends prevailing in the APAC swabs collection kit market along with the drivers and restraints pertaining to the market growth. Growing number of coronavirus cases and high surge for accurate and modern swab collection kits are the major factor driving the growth of the APAC swabs collection kit market. However, shortage of expertise and limitation of swab collection kits hinders the growth of APAC swabs collection kit market.
The APAC swabs collection kit market is segmented based on by type, by application, and country. Based on type, the APAC swabs collection kit market is segmented into nasopharyngeal swabs, oropharyngeal swabs, and others. The nasopharyngeal swabs dominated the APAC swabs collection kit market in 2020. Based on application, the APAC swabs collection kit market is segmented into microbiology laboratories, diagnostic laboratories, hospitals and clinics, home tests, and others. The hospitals and clinics segment dominated the APAC swabs collection kit market in 2020. Based on country, the APAC swabs collection kit market is segmented into China, Japan, India, Australia, South Korea, Rest of APAC. The India segment dominated the APAC swabs collection kit market in 2020.
BD; Puritan Medical Products Company LLC; Laboratory Corporation of America Holdings; HiMedia Laboratories; THERMO FISHER SCIENTIFIC INC.; Hardy Diagnostics; VIRCELL S.L; BTNX, Inc; Formlabs; Lucence Diagnostics; Quidel Corporation; DiaSorin S.P.A; Copan Italia S.P.A; Norgen Biotek Corp; Hologic, Inc; Quest Diagnostics Incorporated; Abbott; Lynn Peavey Company; and QIAGEN by Altair are among the leading companies in the APAC swabs collection kit market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2020, Formlabs launched its 3D Printed Test Swabs for COVID 19 Testing in March of 2020. These swabs are typically used for testing for influenza and other respiratory infections. The current and impending supply chain shortages are serious enough that clinicians are designing and testing their own swabs as quickly and safely as possible.
Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com